Legal News

Life Science Companies to receive £277m in government and private investment

Published on: 28 March 2023
Published by LNB News

LNB News 28/03/2023

Document Information

Issue Date: 28 March 2023

Published Date: 28 March 2023

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The UK Government has announced a £277m investment into life sciences companies as part of the first tranche of winning grants from the Life Sciences Innovative Manufacturing Fund (LSIMF). The successful companies include Ipsen, Pharmaron, Touchlight, and Randox, which will use the money to support the manufacture of medicines for neurological conditions, critical gene therapy and vaccine components, commercial scale manufacture of DNA, and the modernisation of diagnostic tests. The funding also aims to help grow an innovative economy across the UK, supporting more than 500 jobs at companies across the UK.

Popular documents